Despite the positive revenue trends, the product gross margin experienced a decline from the previous year, attributed to the sales of newer products that have not yet achieved scale and the associated production inefficiencies. However, Surmodics Inc ( NASDAQ:SRDX ) managed to reduce operating costs significantly, primarily due to lower research and development expenses and the implementation of a spending reduction plan.